Within the AstraZeneca Cell Therapy Unit (CTU), our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units.

The Executive Director, Global Product Leader (GPL – Solid Tumor Franchise) - will have overall leadership and accountability for global, cross-functional teams delivering discovery and clinical studies with embedded translational medicine research to establish proof-of-concept data enabling registrational investment strategies. This individual will be accountable for the strategic leadership and execution of clinical development and commercialization plans, aligning prioritization across oncology research units to advance the solid tumor-directed c...